Michelle Callegan to Anti-Bacterial Agents
This is a "connection" page, showing publications Michelle Callegan has written about Anti-Bacterial Agents.
Connection Strength
2.276
-
The cereus matter of Bacillus endophthalmitis. Exp Eye Res. 2020 04; 193:107959.
Score: 0.478
-
Efficacy of vitrectomy in improving the outcome of Bacillus cereus endophthalmitis. Retina. 2011 Sep; 31(8):1518-24.
Score: 0.266
-
Toward improving therapeutic regimens for Bacillus endophthalmitis. Invest Ophthalmol Vis Sci. 2008 Apr; 49(4):1480-7.
Score: 0.210
-
Bacterial endophthalmitis: therapeutic challenges and host-pathogen interactions. Prog Retin Eye Res. 2007 Mar; 26(2):189-203.
Score: 0.194
-
Virulence factor profiles and antimicrobial susceptibilities of ocular bacillus isolates. Curr Eye Res. 2006 Sep; 31(9):693-702.
Score: 0.188
-
Novel Anti-Microbial/Anti-Inflammatory Combination Improves Clinical Outcome of Bacillus cereus Endophthalmitis. Invest Ophthalmol Vis Sci. 2025 Jan 02; 66(1):39.
Score: 0.168
-
Antibacterial activity of the fourth-generation fluoroquinolones gatifloxacin and moxifloxacin against ocular pathogens. Adv Ther. 2003 Sep-Oct; 20(5):246-52.
Score: 0.153
-
Roles of CCL2 and CCL3 in intraocular inflammation during Bacillus endophthalmitis. Exp Eye Res. 2022 11; 224:109213.
Score: 0.143
-
C-X-C Chemokines Influence Intraocular Inflammation During Bacillus Endophthalmitis. Invest Ophthalmol Vis Sci. 2021 11 01; 62(14):14.
Score: 0.135
-
Corticosteroid and antibiotic therapy for bacillus endophthalmitis. Arch Ophthalmol. 2001 Sep; 119(9):1391-3.
Score: 0.133
-
Modeling intraocular bacterial infections. Prog Retin Eye Res. 2016 09; 54:30-48.
Score: 0.092
-
The impact of short-term topical gatifloxacin and moxifloxacin on bacterial injection after hypodermic needle passage through human conjunctiva. J Ocul Pharmacol Ther. 2013 Jun; 29(5):450-5.
Score: 0.074
-
Effectiveness of specific antibiotic/steroid combinations for therapy of experimental Pseudomonas aeruginosa keratitis. Curr Eye Res. 1995 Mar; 14(3):229-34.
Score: 0.021
-
Pharmacokinetic considerations in the treatment of bacterial keratitis. Clin Pharmacokinet. 1994 Aug; 27(2):129-49.
Score: 0.020